Comparison of Anterior Vaginal Sacrospinofixation With Laparoscopic Promontofixation for the Treatment of Anterior and Apical Genitourinary Prolapse
- Conditions
- Prolapse Genital
- Interventions
- Procedure: promontofixationProcedure: sacrospinofixation
- Registration Number
- NCT03200327
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
The investigators anticipate a reduced risk of post-operational de novo stress urinary incontinence following surgery for vaginal sacrospinofixation, associated with reduced costs, comparable functional and anatomical efficacy and no increase in morbidity and rate of dyspareunia with the new treatment
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 55
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
- Patient must be available for 12 month follow-up
- Patient is ≥50 and <80 years old
- Patient has pelvic prolapse stage 2 or above according to international POP-Q score, concerning the anterior and apical compartments, justifying surgical treatment
- Patients not having preoperational stress urinary incontinence or having mild stress urinary incontinence not causing significant functional problems (response <2 to question 17 of PFDI-20 questionnaire). It is possible that patients with hidden stress urinary incontinence will be recruited
- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
- The patient is under safeguard of justice or state guardianship
- The subject refuses to sign the consent
- Patient with communication issues preventing comprehension of information and administration of questionnaires
- Pelvic prolapse not affect anterior and apical compartments, regardless of stage
- Patient with preoperative dyspareunia (patients with mild sexual discomfort related to prolapse may be included
- Patient presents with preoperative stress urinary incontinence responsible of significant functional incapacity (response ≥2 to question 17 of PFDI-20 questionnaire).
- Indication for concomitant suburethral sling
- Patient with previous history of surgery for stress urinary incontinence
- Indication of concomitant perineorrhaphy surgery with or without myorrhaphy (in both groups).
- Contra-indication for general anesthetic
- Current urinary infection
- Current vaginal infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description laparoscopic promontofixation promontofixation - Anterior vaginal sacrospinofixation sacrospinofixation -
- Primary Outcome Measures
Name Time Method Compare the rate of de novo problematic stress urinary incontinence, operable or not, between groups response 12 months after intervention ≥ 2 to question 17 of PFDI-20 questionnaire
- Secondary Outcome Measures
Name Time Method Compare quality of life associated to pelvic floor issues between groups at 6 weeks and 12 months after intervention PFIQ questionnaire
Re-intervention for suburethral band (BSU) in de novo SUI between groups up to 12 months after the initial intervention binary: yes/no.
Compare general quality of life between groups at 6 weeks and 12 months after intervention SF12 questionnaire
Compare global satisfaction between groups at 6 weeks and 12 months after intervention PGI-I questionnaire
De novo dyspareunia rate the dyspareunia between groups 12 months after the initial intervention ≥ 2 to question 11 of the PISQ-IR questionnaire.
Compare anatomical prolapse symptoms between groups at 6 weeks and 12 months after intervention POP-Q questionnaire
Compare functional prolapse symptoms between groups at 6 weeks and 12 months after intervention PFDI-20 questionnaire
Quality of sexual life between groups 12 months after the initial intervention PISQ-IR questionnaire.
Compare perioperational morbidity between groups at 6 weeks and 12 months after intervention complication assessed as stage ≥2 on Clavien-Dindo classification, or according to the ICS/IUGA classification.
Compare direct and indirect costs of the 2 interventions 12 months after intervention
Trial Locations
- Locations (6)
CHU de clermont-Ferrand
🇫🇷clermont-Ferrand, France
CHU de Lille
🇫🇷Lille, France
CHU de Montpellier
🇫🇷Montpellier, France
Clinique Beau-Soleil
🇫🇷Montpellier, France
CHU Nimes
🇫🇷Nîmes, France
HFME - Hospices Civils de Lyon
🇫🇷Lyon, France